Rapport Therapeutics Files 2025 Proxy Statement
Ticker: RAPP · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 2012593
| Field | Detail |
|---|---|
| Company | Rapport Therapeutics, Inc. (RAPP) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Rapport Therapeutics DEF 14A is out - proxy vote coming up for directors & auditors.
AI Summary
Rapport Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 24, 2025, for its annual meeting on June 17, 2025. The filing details the company's governance and proposals to be voted on by shareholders, including the election of directors and the ratification of its independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information about the company's leadership and upcoming votes, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a standard proxy filing for an annual meeting, not indicating new or unusual risks.
Key Players & Entities
- Rapport Therapeutics, Inc. (company) — Registrant
- 0001193125-25-092133 (filing_id) — Accession Number
- 20250424 (date) — Filing Date
- 20250617 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information regarding the company's annual meeting of stockholders, including proposals to be voted upon, such as the election of directors and ratification of the independent registered public accounting firm.
When is Rapport Therapeutics' annual meeting scheduled?
The annual meeting of stockholders for Rapport Therapeutics is scheduled for June 17, 2025.
Who is the filer of this proxy statement?
The filer of this proxy statement is Rapport Therapeutics, Inc.
What is the company's Standard Industrial Classification (SIC) code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
Rapport Therapeutics' fiscal year ends on December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding Rapport Therapeutics, Inc. (RAPP).